AV
$27.03
-1.11
(-3.93%)
As of Oct 5, 2026, 3:43 PM EDT
Price history
Avalyn Pharma (AVLN) is trading down at $27.03 (-3.93%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: April 30, 2026 · $18.00 offering · NASDAQ · View IPO details →
Avalyn Pharma net income history
Net income
| Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|
| Income statement | ||||
| Operating income | −$18.7M | −$21.8M | −$27.9M | −$31.3M |
| Net income | −$17.5M | −$20.2M | −$26.9M | −$28.9M |
| EPS (diluted) | −$63.24 | −$17.63 | −$21.83 | −$0.98 |
| Balance sheet | ||||
| Cash and equivalents | $28.8M | $61.3M | $92.3M | $264.2M |
| Total assets | — | — | $135.7M | $425.4M |
| Total liabilities | — | — | $27.7M | $27.1M |
| Long-term debt | — | — | $14.8M | $14.8M |
| Shareholders' equity | −$191.6M | −$194.4M | −$264.2M | $398.3M |
| Cash flow | ||||
| Operating cash flow | −$19.3M | −$20.7M | −$29.9M | −$26.1M |
| Capital expenditure | $8.00K | $0 | $318.0K | $269.0K |
| Free cash flow | −$19.3M | −$20.7M | −$30.2M | −$26.3M |
From Avalyn Pharma's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Filings on SEC EDGAR →
About Avalyn Pharma
- Headquarters
- Boston, Massachusetts From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International